Recombinant antibody production utilizes Chinese hamster ovary (CHO) cells due to their robustness in expressing complex biologics. Enhancing these processes involves fine-tuning various parameters, including cell line development, media formulation, and bioreactor settings. A key goal is to amplify antibody production while minimizing production e